New American guidelines for chronic coronary disease (CCD) modify management considerations for a heterogeneous group that includes people with or without angina, a history of coronary ...

Beta blockers may provide no clinical benefit to patients who maintain normal heart function following a heart attack, according to a study published Aug. 30 in The New England Journal of Medicine.

Beta-blockers are relatively common medications used to treat high blood pressure, abnormal heart rhythms, and a range of other conditions. They work by blocking epinephrine (a.k.a. adrenaline), which ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Beta-blocker use did not reduce risk for death or new MI ...

NEW YORK CITY — A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn't benefit the vast majority of patients and may contribute to a higher ...

Madrid, Spain – 30 August 2025: Beta-blocker therapy showed no evidence of an effect on all-cause death, reinfarction or heart failure admission in patients with myocardial infarction (MI) managed ...

NEW YORK (Reuters Health) - A class of drugs once widely used to lower blood pressure -- beta-blockers -- may actually lead to heart problems, a study concludes. Beta-blockers work by slowing the ...

ATLANTA — Beta blockers are a mainstay in cardiovascular treatment, frequently given to patients after heart attacks. But a new large trial turns that convention on its head, suggesting that the drugs ...

One way or another, beta blockers are always in the news. Take, for instance, Los Angeles Chargers Head Coach Jim Harbaugh, who revealed in October that he's part of a growing group of Americans who ...